Literature DB >> 8804368

Evaluation of the solid hepatic mass.

R A Rubin1, D G Mitchell.   

Abstract

With the expanding use of abdominal imaging studies, evaluation of solid hepatic masses has become a common clinical challenge. In this review, the clinicopathologic characteristics of the most common causes of solid hepatic masses have been discussed. As the case scenarios demonstrate, the appropriate selection of imaging techniques and proper management of an individual patient depend on the clinical context. Often, complementary radiologic studies are necessary to narrow the differential diagnosis. Percutaneous biopsy or surgery is frequently required to confirm the diagnosis and to exclude malignancy definitively. The evaluation and management of solid hepatic masses is a cooperative venture that requires a multidisciplinary approach.

Entities:  

Mesh:

Year:  1996        PMID: 8804368     DOI: 10.1016/s0025-7125(05)70473-9

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  4 in total

Review 1.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

2.  Contrast-enhanced ultrasound in diagnosis and characterization of focal hepatic lesions.

Authors:  Inés Gómez Molins; Juan Manuel Fernández Font; Juan Carrero Alvaro; Jose Luís Lledó Navarro; Marta Fernández Gil; Conrado M Fernández Rodríguez
Journal:  World J Radiol       Date:  2010-12-28

Review 3.  Benign Liver Tumors.

Authors:  Karl J Oldhafer; Victoria Habbel; Katja Horling; Georgios Makridis; Kim Caroline Wagner
Journal:  Visc Med       Date:  2020-08-04

4.  Indications for liver surgery in benign tumours.

Authors:  Margot Fodor; Florian Primavesi; Eva Braunwarth; Benno Cardini; Thomas Resch; Reto Bale; Daniel Putzer; Benjamin Henninger; Rupert Oberhuber; Manuel Maglione; Christian Margreiter; Stefan Schneeberger; Dietmar Öfner; Stefan Stättner
Journal:  Eur Surg       Date:  2018-05-22       Impact factor: 0.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.